Skin News and Research

RSS

Low-dose infusion of ketamine completely relieves pain of complex regional pain syndrome

Limited, low-dose infusions of a widely used anesthetic drug may relieve the often intolerable and debilitating pain of Complex Regional Pain Syndrome (CRPS), a Penn State Milton S. Hershey Medical Center researcher found.

23 Sep 2004

Promising early results in a study of a medication to treat kleptomania

Kleptomania, the guilt-ridden, impulsive stealing of inexpensive and unneeded items, often goes untreated as many who suffer from the disorder hesitate to seek help out of fear of being turned in for their illegal activities.

23 Sep 2004

A naturally occurring chemical that may repel yellow fever mosquitoes can now be made in the laboratory

Gaur acid is a natural skin secretion of the gaur, an Asian wild ox. Preliminary evidence suggests that this chemical discourages the landing and feeding of Aedes aegypti, a common mosquito that carries and transmits the yellow fever virus in some parts of the world.

23 Sep 2004

Acupuncture more effective at reducing nausea and vomiting after major breast surgery than the leading medication

The researchers also found that patients who underwent the 5,000-year-old Chinese practice reported decreased postoperative pain and increased satisfaction with their postoperative recovery. In conducting the trial, the researchers also demonstrated that the pressure point they stimulated possesses previously unknown pain-killing properties.

22 Sep 2004

University of Arizona spin-off investigates DNA damage to human skin

Niadyne, Inc., a Tucson-based spin-off biopharmaceutical company co-founded by two University of Arizona professors, has received a Small Business Innovation Research grant of nearly $750,000 to continue investigating the prevention of DNA damage to human skin

22 Sep 2004

New gene therapy technique may help treat Alzheimer's disease

Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease.

21 Sep 2004

Laser therapy and tacrolimus ointment best for vitiligo

Patients with vitiligo, a skin disorder characterized by patches of white, or de-pigmented skin, had better repigmentation of these patches when they were treated with a combination of laser therapy and tacrolimus ointment than patients treated with laser therapy alone

21 Sep 2004

Breast reconstruction at the time of mastectomy does not delay post-operative chemotherapy for women with breast cancer

“The findings weren’t a surprise to us, but we wanted to document the safety of immediate breast reconstruction so that surgeons in other settings can have the same confidence in the approach,” Bold said.

20 Sep 2004

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

The eradication of brain tumors in mice following treatment with a novel drug suggests that certain cancers might one day be cured without the use of toxic chemotherapy and radiation.

20 Sep 2004

Non-human primates should never be considered as source animals for any future clinical trials of animal-to-human transplantation

Australia’s leading health advisory body, the National Health and Medical Research Council, says there should be a five-year moratorium on any clinical research into animal-to-human whole organ transplants in Australia.

20 Sep 2004

New Australian biotech speeds up healing for burns and wounds

A Queensland PhD student’s discovery speeds up tissue growth and repair and sparks off a new listed biotech company.

20 Sep 2004

Mitomycin C offers limited benefit in reducing unsightly scars

The tendency for extreme scarring is one reason many African Americans avoid plastic surgery and other surgical incisions. Though surgeons continue to develop less invasive techniques that minimize scarring, other options are needed to help these individuals who are prone to developing keloid scars.

17 Sep 2004

Strep A is showing up in increased numbers of head and neck abscesses

Head and neck abscesses are infrequent complications of upper respiratory infections, but they can occur suddenly and be rapidly progressive. If untreated, the abscesses can lead to airway obstruction, vision loss, intracranial infections, and even death.

17 Sep 2004

Neck surgeons brush up on West Nile virus

Neck Surgery Foundation Annual Meeting & OTO EXPO, being held September 19-22, 2004, at the Jacob K. Javits Convention Center, New York City, NY.

17 Sep 2004

Titanium rib becomes 1st new FDA-approved spine deformity treatment in 40 years

The Vertical Expandable Prosthetic Titanium Rib (VEPTR), a device that has saved the lives of 300 infants and young children who otherwise would have died from lack of breath, has been approved by the U.S. Food and Drug Administration (FDA).

16 Sep 2004

Severe infections with flesh-eating bacteria are considerably more common than expected

In an EU project covering 11 countries, headed by Lund University in Sweden, it was calculated that some 1,000 cases would be found over an initial 1½-year period. Fully 5,000 were identified.

16 Sep 2004

Protein that causes juvenile Batten disease also plays a key role in normal cell function

The aberrant protein that causes juvenile Batten disease, a fatal neurodegenerative disorder of childhood, also plays a key role in normal cell function, Duke University Medical Center researchers have found.

16 Sep 2004

Cancer drug effective at treating lupus

A drug now used to treat a type of cancer appears to be very effective at treating lupus, with just one injection easing symptoms in several patients for a year or more.

16 Sep 2004

Researchers get a grip on marijuana

Now researchers at Stanford University School of Medicine are a step closer to understanding how the drug's active ingredients - tetrahydrocannabinol and related compounds, called cannabinoids - may exert their effects.

16 Sep 2004

Cryoablation preferred option for treatment of breast fibroadenoma

Sanarus Inc., a developer of minimally invasive diagnostic and treatment tools for breast disease, announced today that twelve-month follow-up data from a peer-reviewed, prospective multicenter study demonstrates that cryoablation is a preferred first-line treatment for breast fibroadenoma for women who do not want to undergo open surgery.

14 Sep 2004

Skin News and Research

Low-dose infusion of ketamine completely relieves pain of complex regional pain syndrome

Promising early results in a study of a medication to treat kleptomania

A naturally occurring chemical that may repel yellow fever mosquitoes can now be made in the laboratory

Acupuncture more effective at reducing nausea and vomiting after major breast surgery than the leading medication

University of Arizona spin-off investigates DNA damage to human skin

New gene therapy technique may help treat Alzheimer's disease

Laser therapy and tacrolimus ointment best for vitiligo

Breast reconstruction at the time of mastectomy does not delay post-operative chemotherapy for women with breast cancer

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

Non-human primates should never be considered as source animals for any future clinical trials of animal-to-human transplantation

New Australian biotech speeds up healing for burns and wounds

Mitomycin C offers limited benefit in reducing unsightly scars

Strep A is showing up in increased numbers of head and neck abscesses

Neck surgeons brush up on West Nile virus

Titanium rib becomes 1st new FDA-approved spine deformity treatment in 40 years

Severe infections with flesh-eating bacteria are considerably more common than expected

Protein that causes juvenile Batten disease also plays a key role in normal cell function

Cancer drug effective at treating lupus

Researchers get a grip on marijuana

Cryoablation preferred option for treatment of breast fibroadenoma

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News